---
title: "清科創業 5 月 9 日斥資 1152 港元回購 800 股"
description: "智通財經 APP 訊，清科創業發佈公告，於 2025 年 5 月 9 日斥資 1152 港元回購股份 800 股。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/239521475.md"
published_at: "2025-05-09T09:14:03.000Z"
---

# 清科創業 5 月 9 日斥資 1152 港元回購 800 股

> 智通財經 APP 訊，清科創業發佈公告，於 2025 年 5 月 9 日斥資 1152 港元回購股份 800 股。

智通財經 APP 訊，清科創業 (01945) 發佈公告，於 2025 年 5 月 9 日斥資 1152 港元回購股份 800 股。

### Related Stocks

- [01945.HK - 清科控股](https://longbridge.com/zh-HK/quote/01945.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Standard Chartered PLC (OTCMKTS:SCBFF) Sees Significant Growth in Short Interest | Standard Chartered PLC (OTCMKTS:SCBFF) experienced a significant increase in short interest, rising 21.1% to 210,583 sha | [Link](https://longbridge.com/zh-HK/news/276119010.md) |
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/zh-HK/news/276056763.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-HK/news/276051793.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/zh-HK/news/276035104.md) |
| Al Manar Financing And Leasing Q4 Profit 1.1 Million Dinars | AL MANAR FINANCING AND LEASING COMPANY :AL MANAR FINANCING AND LEASING Q4 NET PROFIT ATTRIBUTABLE 1.1 MILLION DINARSAL M | [Link](https://longbridge.com/zh-HK/news/276325298.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。